Additional file 1: of Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

Smolen, Josef; van Vollenhoven, Ronald; Kavanaugh, Arthur; Strand, Vibeke; Vencovsky, Jiri; Schiff, Michael; LandewĂŠ, Robert; Haraoui, Boulos; Arendt, Catherine; Mountian, Irina; Carter, David; van der Heijde, DĂŠsirĂŠe

doi:10.6084/m9.figshare.c.3645584_D1.v1

13075_2015_767_MOESM1_ESM.pdf (1.04 MB)

Additional file 1: of Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

journal contribution

posted on 2015-09-10, 05:00 authored by Josef Smolen, Ronald van Vollenhoven, Arthur Kavanaugh, Vibeke Strand, Jiri Vencovsky, Michael Schiff, Robert LandewĂŠ, Boulos Haraoui, Catherine Arendt, Irina Mountian, David Carter, DĂŠsirĂŠe van der Heijde

Supplementary material. Additional supplementary data tables and figures referred to in the manuscript. (PDF 1062 kb)